191 related articles for article (PubMed ID: 23451111)
1. MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis.
Ma Y; Bian J; Cao H
PLoS One; 2013; 8(2):e56918. PubMed ID: 23451111
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of the MDM2 T309G polymorphism and gastric cancer risk.
Song B; Duan ZY; Zhong YH; Lei N; Yang YQ; Luo KY
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6649-51. PubMed ID: 24377582
[TBL] [Abstract][Full Text] [Related]
3. Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis.
Ding H; Dai Y; Ning Z; Fan N; Wang Z; Li P; Zhang L; Tao Y; Wang H
Medicine (Baltimore); 2016 Mar; 95(12):e2941. PubMed ID: 27015167
[TBL] [Abstract][Full Text] [Related]
4. MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis.
Wan Y; Wu W; Yin Z; Guan P; Zhou B
BMC Cancer; 2011 May; 11():208. PubMed ID: 21619694
[TBL] [Abstract][Full Text] [Related]
5. MDM2 SNP309 polymorphism and breast cancer risk: a meta-analysis.
Zhao E; Cui D; Yuan L; Lu W
Mol Biol Rep; 2012 Apr; 39(4):3471-7. PubMed ID: 21725850
[TBL] [Abstract][Full Text] [Related]
6. Cigarette smoking, MDM2 SNP309, gene-environment interactions, and lung cancer risk: a meta-analysis.
Bai J; Dai J; Yu H; Shen H; Chen F
J Toxicol Environ Health A; 2009; 72(11-12):677-82. PubMed ID: 19492228
[TBL] [Abstract][Full Text] [Related]
7. MDM2 SNP309 polymorphism and colorectal cancer risk: a meta-analysis.
Cao X; Zhang T; Zhao Z; Zhao T
DNA Cell Biol; 2012 Mar; 31(3):355-9. PubMed ID: 21770737
[TBL] [Abstract][Full Text] [Related]
8. An updated meta-analysis on the association of MDM2 SNP309 polymorphism with colorectal cancer risk.
Qin X; Peng Q; Tang W; Lao X; Chen Z; Lai H; Deng Y; Mo C; Sui J; Wu J; Zhai L; Yang S; Li S; Zhao J
PLoS One; 2013; 8(9):e76031. PubMed ID: 24098760
[TBL] [Abstract][Full Text] [Related]
9. MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis.
Peng Q; Mo C; Qin A; Lao X; Chen Z; Sui J; Wu J; Zhai L; Yang S; Qin X; Li S
J Exp Clin Cancer Res; 2013 Nov; 32(1):85. PubMed ID: 24423195
[TBL] [Abstract][Full Text] [Related]
10. Association between MDM2 promoter SNP309 T/G polymorphism and liver cancer risk - a meta-analysis.
Ma HB; Huang T; Han F; Chen WY
Asian Pac J Cancer Prev; 2012; 13(6):2841-6. PubMed ID: 22938470
[TBL] [Abstract][Full Text] [Related]
11. MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis.
Li Y; Zhao H; Sun L; Huang L; Yang Q; Kong B
Hum Cell; 2011 Jun; 24(2):57-64. PubMed ID: 21547352
[TBL] [Abstract][Full Text] [Related]
12. Association between MDM2 SNP309 and endometrial cancer risk: A PRISMA-compliant meta-analysis.
Zou X; Zhang Y; Zhang L; Li J; Zhu C; Cheng Q; Zhou J; Chen Y
Medicine (Baltimore); 2018 Dec; 97(49):e13273. PubMed ID: 30544386
[TBL] [Abstract][Full Text] [Related]
13. The MDM2 309 T/G polymorphism is associated with head and neck cancer risk especially in nasopharyngeal cancer: a meta-analysis.
Zhang Y; Bai Y; Zhang Y; Guan J; Chen L
Onkologie; 2012; 35(11):666-70. PubMed ID: 23147543
[TBL] [Abstract][Full Text] [Related]
14. A cohort study on the association of MDM2 SNP309 with lung cancer risk in Bangladeshi population.
Reza HA; Anamika WJ; Chowdhury MMK; Mostafa MG; Uddin MA
Korean J Intern Med; 2020 May; 35(3):672-681. PubMed ID: 32392664
[TBL] [Abstract][Full Text] [Related]
15. Interaction of Helicobacter pylori with genetic variants in the MDM2 promoter, is associated with gastric cancer susceptibility in Chinese patients.
Wang X; Yang J; Ho B; Yang Y; Huang Z; Zhang Z; Zhang G
Helicobacter; 2009 Oct; 14(5):114-9. PubMed ID: 19751436
[TBL] [Abstract][Full Text] [Related]
16. Association between MDM2 SNP309 T>G and risk of gastric cancer: a meta-analysis.
Tian X; Tian Y; Ma P; Sui CG; Meng FD; Li Y; Fu LY; Jiang T; Wang Y; Ji FJ; Fang XD; Jiang YH
Asian Pac J Cancer Prev; 2013; 14(3):1925-9. PubMed ID: 23679294
[TBL] [Abstract][Full Text] [Related]
17. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
[TBL] [Abstract][Full Text] [Related]
18. MDM2 SNP309T>G polymorphism with hepatocellular carcinoma risk: a meta-analysis.
Liu GY; Jiang DK; Shen SQ; Yu L
Arch Med Res; 2011 Feb; 42(2):149-55. PubMed ID: 21565629
[TBL] [Abstract][Full Text] [Related]
19. Involvement of p53 R72P polymorphism in the association of MDM2-SNP309 with breast cancer.
Leu JD; Wang CY; Tsai HY; Lin IF; Chen RC; Lee YJ
Oncol Rep; 2011 Jun; 25(6):1755-63. PubMed ID: 21479369
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of MDM2 SNP309 polymorphism on breast cancer risk along with race: a meta-analysis.
Economopoulos KP; Sergentanis TN
Breast Cancer Res Treat; 2010 Feb; 120(1):211-6. PubMed ID: 19590949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
